Letter
Infliximab-induced hypoglycemia, a rare but relevant side effect
364-365
Lucía Zabalza, Joaquín de Carlos, Iranzu Ezcurra, María Rullán, Alfonso Elosua, Saioa Rubio, Lluis Forga, Cristina Rodríguez,
Tumor necrosis factor (TNF) inhibitors are part of the therapeutic arsenal for many immune-mediated diseases and, especially in inflammatory bowel disease (IBD), have led to a change in the management of this disease.
New comment
Comments
No hay comentarios para este artículo.